Skip to content

EBIT at other companies

Pfizer logo
PfizerPFE
McKesson logo
McKessonMCK
Cencora logo
CencoraCOR
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
BridgeBio Pharma logo
BridgeBio PharmaBBIO
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST

Other financials

Income statement

See full
Revenue$3.5B+8.1%
Gross profit$1.2B-0.3%
Operating income-$79.7M+97.2%
Net income$176.4M+106%
EPS (diluted)$0.15+106%

Balance sheet

See full
Cash & equivalents$1.8B+139%
Total debt$14.6B+1.0%
Total equity$14.7B-6.3%
Total assets$36.8B-4.3%

Cash flow

See full
Operating cash flow$388.3M-27.5%
CapEx$39.9M-6.3%
Free cash flow$348.4M-29.3%

Valuation

See full
Market cap$17.9B+49.6%
Enterprise value$30.71B+17.7%
P/S1.2×+0.4×

Profitability

See full
Gross margin34.4%-2.5pp
Operating margin1%
Net margin-2%-1.0pp
FCF margin12.3%-1.0pp

Returns & leverage

See full
Return on equity-2%-0.9pp
Debt / equity+0.1×
Current ratio1.6×-0.1×

Where this comes from

Calculated from Viatris’s reported figures.

The official record: Viatris’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viatris's ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Viatris's EBIT?
Viatris (VTRS) reported EBIT of -$79.7M in Q1 2026.
How has Viatris's EBIT changed year-over-year?
Viatris's EBIT increased by 97.2% year-over-year, from -$2.88B to -$79.7M.
What is the long-term trend for Viatris's EBIT?
Over 3 years (2021 to 2025), Viatris's EBIT has grown at a 327.9% compound annual growth rate (CAGR), from -$34M to -$2.66B.
What does EBIT mean?
Profit before interest and taxes — the business's core earning power.
How do you interpret EBIT?
Higher is better. Because it adds back interest, EBIT compares earning power across firms with very different debt loads — the base for interest coverage and the EV/EBIT multiple. For filers reporting operating income it equals that line, excluding non-operating swings.
How does EBIT compare across companies?
Comparable across companies regardless of leverage or tax domicile; the standard 'earning power' line for cross-company analysis. Least meaningful for banks and insurers.